CrossTalk proposal: Intramyocellular ceramide accumulation does modulate insulin resistance
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The oversupply of nutrients to skeletal muscle produces metabolic by-products that drive insulin resistance, predisposing people to diabetes, atherosclerosis and heart disease. Ceramides, reactive oxygen species, diacylglycerols, branched chain amino acids, acylcarnitines, citric acid cycle intermediates and other metabolites have all been implicated as antagonists of insulin action, but their relative importance is a source of contention. Here we advance the position that ceramides are both sufficient and necessary for obesity-induced insulin resistance. Ceramides antagonize insulin signalling by blocking activation of the anabolic enzyme Akt/PKB, inhibiting glucose uptake and impairing storage of nutrients as glycogen or triglyceride (Chaurasia & Summers, 2015) (Fig. 1). These sphingolipids also disrupt lipid metabolism, particularly in the liver, by inhibiting oxidation and stimulating fatty acid uptake (Chaurasia & Summers, 2015). Three lines of evidence support roles in insulin resistance in vivo. First, ceramide reduction interventions invariably improve insulin sensitivity in mice, rats and hamsters. Second, lipidomic profiling studies reveal strong relationships between tissue ceramides and insulin resistance in humans, non-human primates and rodents. Third, glucocorticoids, inflammatory agonists and adiponectin modulate insulin sensitivity by positively or negatively altering ceramide synthesis or metabolism. Here we highlight a subset of prominent studies conducted in model systems and humans revealing roles for the sphingolipid in muscle insulin resistance and metabolic disorders. Studies in isolated muscle or cultured myotubes reveal that the effects can be tissue-autonomous. Exogenous ceramides antagonize insulin signalling or action in cultured myocytes or isolated fibres. Moreover, inhibition of ceramide synthesis (i.e. myriocin, fumonisin B1, or siRNA-mediated knockdown of Spt subunits or Des-1) or stimulation of ceramide degradation (e.g. acid ceramidase overexpression) negates lipid-antagonism of insulin signalling in these systems (Chaurasia & Summers, 2015). A provocative hypothesis that is gaining traction is that muscle ceramides may also be also delivered through the circulation. Infusion of ceramide-enriched low density lipoproteins reduced whole-body glucose owing to a reduction in glucose disposal in skeletal muscle (Boon et al. 2013). Depletion of ceramides from these lipoproteins rendered them ineffectual as insulin antagonists. These data may explain why tissue-specific reduction of sphingolipid synthesis in adipose tissue or the liver reduces serum ceramides and markedly improves whole body and/or muscle insulin sensitivity (Turpin et al. 2014; Xia et al. 2015). The preponderance of lipid profiling studies in humans demonstrate relationships between ceramides and insulin resistance. For example, elevations in muscle ceramides were reported in individuals with general or abdominal obesity (Amati et al. 2011; Coen et al. 2013; de la Maza et al. 2015) in association with muscle insulin resistance (Adams et al. 2004; Coen et al. 2010; Amati et al. 2011). These cross-sectional observations are not universal (Skovbro et al. 2008), and this discordance is the source of the existing controversy. Associations between liver ceramides and hepatic insulin resistance (Longato et al. 2012) and between adipose ceramides and fatty liver disease (Kolak et al. 2007) are also reported. Insulin-sensitizing treatments (metformin, pioglitazone, exercise, bariatric surgery, etc.) reduce ceramides. Both diet-induced weight loss (Dube et al. 2011) and exercise training (Dube et al. 2008, 2011; Amati et al. 2011) lower muscle ceramide levels and enhance muscle insulin sensitivity. Profound weight loss caused by bariatric surgery also reduced muscle ceramides in conjunction with improved insulin sensitivity (Coen et al. 2015). Superimposing exercise after this surgery-induced weight loss further reduced specific ceramide species (Coen et al. 2015). In contrast, levels of diacylglycerols in skeletal muscle were not altered with bariatric surgery-induced weight loss (Coen et al. 2015), nor were they decreased by chronic exercise training (Amati et al. 2011). To the contrary, muscle diacylglcyerol levels were actually higher in endurance-trained athletes who have markedly high insulin sensitivity in skeletal muscle (Amati et al. 2011). Infusion of a lipid emulsion into humans induces insulin resistance. The intervention increases muscle diacylglycerols, but not ceramides (Itani, 2002; Nowotny et al. 2013; Szendroedi et al. 2014). This triglyceride emulsion is comprised primarily of unsaturated lipids, which could explain the lack of observed increases in ceramides. Indeed, rodent studies using lipid infusion cocktails reveal that saturated fats induce insulin resistance via ceramide-dependent mechanisms, while unsaturated fats antagonize insulin action through a different mechanism (Holland et al. 2007). Hi
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232 · cited 1×
“…C© 2016 The Physiological Society Adiponectin elicits its broad spectrum of metabolic benefits by degrading ceramides The Scherer group recently attributed the broad spectrum of anti-diabetic and cardioprotective actions of adiponectin to the activation of a ceramidase (Holland et al. 2011).”
BackgroundSelf-citationReceptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., Davis, K. E., Bikman, B. T., Halberg, N., Rutkowski, J. M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2277 · Cited by 892
Self-citationRole of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans
Szendroedi, J., Yoshimura, T., Phielix, E., Koliaki, C., Marcucci, M., Zhang, D., Jelenik, T., Müller, J., Herder, C., Nowotny, P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409229111 · Cited by 415 · cited 1×
“The intervention increases muscle diacylglycerols, but not ceramides (Itani, 2002; Nowotny et al. 2013; Szendroedi et al. 2014).”
BackgroundSkeletal Muscle Triglycerides, Diacylglycerols, and Ceramides in Insulin Resistance
Amati, F., Dubé, J. J., Alvarez-Carnero, E., Edreira, M. M., Chomentowski, P., Coen, P. M., Switzer, G. E., Bickel, P. E., Stefanovic-Racic, M., Toledo, F. G. S., et al. (2011) · Diabetes · doi:10.2337/db10-1221 · Cited by 395
Self-citationDubé, J. J., Amati, F., Stefanovic-Racic, M., Toledo, F. G. S., Sauers, S. E., & Goodpaster, B. H. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00769.2007 · Cited by 378 · cited 1×
“Both diet-induced weight loss (Dube et al. 2011) and exercise training (Dube et al. 2008, 2011; Amati et al. 2011) lower muscle ceramide levels and enhance muscle insulin sensitivity.”
BackgroundSelf-citationDubé, J. J., Coen, P. M., DiStefano, G., Chacon, A. C., Helbling, N. L., Desimone, M. E., Stafanovic-Racic, M., Hames, K. C., Despines, A. A., Toledo, F. G. S., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00257.2014 · Cited by 83 · cited 1×
“Plasma ceramides are higher in obese children (Lopez et al. 2013) and diabetic adults (Haus et al. 2009) and correlate with the severity of insulin resistance (Haus et al. 2009).”
BackgroundSelf-citationEffect of pioglitazone on plasma ceramides in adults with metabolic syndrome
Warshauer, J. T., Lopez, X., Gordillo, R., Hicks, J., Holland, W. L., Anuwe, E., Blankfard, M. B., Scherer, P. E., & Lingvay, I. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2662 · Cited by 51 · cited 1×
“Studies exploring the effects of insulin-sensitizing pioglitazone treatment on plasma ceramides also demonstrate a correlation between the decrease in plasma ceramides and improved insulin sensitivity (Warshauer et al. 2015).”
Background
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
The crucial role and mechanism of insulin resistance in metabolic disease
Zhao, X., An, X., Yang, C., Sun, W., Ji, H., & Lian, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1149239 · Cited by 557
Sphingolipids and phospholipids in insulin resistance and related metabolic disorders
Meikle, P. J., & Summers, S. A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.169 · Cited by 423
Self-citationThe role of hypoxia-inducible factors in metabolic diseases
Gonzalez, F. J., Xie, C., & Jiang, C. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0096-z · Cited by 407
Roles of diacylglycerols and ceramides in hepatic insulin resistance
Petersen, M. C., & Shulman, G. I. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.04.004 · Cited by 373
Ceramides in Metabolism: Key Lipotoxic Players
Chaurasia, B., & Summers, S. A. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-031620-093815 · Cited by 343
Self-citationMetabolic Messengers: ceramides
Summers, S. A., Chaurasia, B., & Holland, W. L. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0134-8 · Cited by 299
Self-citationHepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease
ter Horst, K. W., Vatner, D. F., Zhang, D., Cline, G. W., Ackermans, M. T., Nederveen, A. J., Verheij, J., Demirkiran, A., van Wagensveld, B. A., Dallinga-Thie, G. M., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1644 · Cited by 88
Metadata
- Authors
- Summers, S. A., & Goodpaster, B. H.
- Venue
- The Journal of Physiology
- Publisher
- Wiley
- Published
- 2016-03-20
- Volume
- 594
- Issue
- 12
- Pages
- 3167-3170
- ISSN
- 0022-3751 (ISSN-L)
- 1469-7793
- OpenAlex
- W2301676523
- Cited by
- 48
- References
- 7
- FWCI
- 3.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.